Archive for the 'Health and medicine' Category

The end of certainty

This is the third in a series related to my cancer treatment. The first posting looked at blood and how its condition affects our mental state. The second, on patienthood, promised more reflection on the way being a patient changes your thinking about risk. So here goes… 

At our first meeting, my surgeon said elegantly, ‘We don’t know what we’re really dealing with, until the lump is in the bucket’.

I can offer the following translation: ‘We have been treating you for months, with assumptions based on biopsies and imaging. But we won’t know anything for sure until we have physically removed and tested the tumour, and had a really good look around.’

Well, the lump went into the bucket and the news was good, as these things go. But there is a strict limit to certainty. As one of the specialist nurses put it, ‘Once you have had cancer, there is always some risk of it recurring. The point of treatment is to change this from being a higher risk to a lower risk.’

Of course, talking about risk is just another way of talking about death. You could fall under a bus tomorrow – someone, somewhere, has statistics on that probability – but most people do not go through the day thinking about it. This is partly because most people don’t think much about death, in general. But even those who are so inclined tend to do it in a hypothetical manner, to explore a personal anxiety, pursue an intellectual enquiry or delve into mythopoetics. A serious illness forces you into a much more instrumental reflection about death, and the uncertainties of life.

Oncologists use online tools, fed by research data from around the world, to calculate the benefit of various treatments on people in different categories. The main factors are age, rate of tumour growth (grade) and extent of cancer spread (stage). A breast cancer patient who is relatively young and healthy will get every type of possible treatment thrown at her, to maximise the chances of both overall survival (OS) and disease-free survival (DFS). For an older patient, or someone with health complications, the risks of treatment – which are very real – may outweigh the potential benefits. 

The risk of dying from the specific new illness is measured against a baseline. Apparently, a woman in her 50s, currently in good health, is considered to have a general, all-purpose 10 percent chance of dying within 10 years from something or the other. Assume that the risk of dying from the newly diagnosed disease is a further 10 percent, you could think in terms of having ‘only’ a 10 percent extra chance of dying. Or you could think, ‘Shit, I’ve just doubled my chances’. Either way, a combined one-in-five chance does not feel very remote.

Medicine has become relatively successful in detecting and treating breast cancer. More women are surviving the disease, although more people are also getting it, in what doctors agree is now a western epidemic. The improvement has percolated into popular thinking. People often say, ‘Oh, I know someone who had that 5/10/15 years ago, and now she’s right as rain/never looking better/ playing 18 holes of golf.’ You feel like a party pooper if you point out that statistically, someone has to be in the percentile of people who die within a few years of diagnosis. The insurance world certainly has my number. 

Most people make the link between risk and illness when they think about getting ill in the first place. The world is full of things that may be carcinogenic, and thus avoided. We try to control these influences, encouraged by a culture that sees ‘no risk’ as an achievable ideal, but who knows what triggers an individual case? Early on, I blamed personal factors such as stress, or the years spent subjecting my body to that giant experiment called IVF. But my case might be part of a more general trend, linked to diet or the environment.

You can think about risk without thinking about numbers – that is where most people start. We ask ourselves, what am I prepared to lose? A breast cancer patient will be more prepared to lose a breast than her life. The numbers then help make decisions: doctors may say that in a particular case, ‘breast conservation’ surgery plus radiotherapy is not more risky that mastectomy, and so she can keep both.

All the same, the patient usually has to travel a long distance to get to a place where numbers provide any help. Numbers are about long-term probabilities, and do not know us as individuals. Numbers are often misused, and have a problematic place in our society, where nothing counts unless you can count it. On their own merits, numbers can provide a fascinating extra way of evaluating the world. But from personal question to generic data, a translation is needed in both directions.

Being a patient

This is the second in a series related to my cancer treatment. The aim is to talk about the personal experience of illness in a broadly analytical way. The first posting looked at blood, and how its condition affects our mental state.

This time I am focusing on patienthood. When you have a serious illness, being a patient is a major occupation, and not just because of the time taken up by medical matters – although, god knows your diary commitments, all of them once Very Important, go through a rapid reclassification after diagnosis. Patienthood also involves, potentially, a change in one’s entire take on life.

One reason is that you receive massive exposure to the way doctors think, and they think in a very particular way. This is partly because of their training and specialist knowledge, but it is also simply because medicine is what they do for a living.

The things that make doctors happy are not always the things that the patient thinks of. When I was first diagnosed, doctors were happy that my tumour tested strongly for hormone receptors, because that meant they could throw an extra treatment at it. I was not happy, because I had a freaking tumour.

Doctors think in general categories rather than individual narratives. Naturally they wish the patient well, but other things are driving them. They want a good outcome – as measured against others in their field – so that their own reputation, and that of their hospital, is enhanced. They value skill and craftsmanship. I do not begrudge this. When the ultrasound specialist first spotted my tumour, after another hospital had missed it entirely, a flash of professional pride passed across her face. At one level, she was pleased. And why wouldn’t she be?

It is not just doctors who think a certain way, but medical establishments in general. When you become a patient, you submit to the system with both your mind and body. There has to be a system, of course, or nothing would get done, but when the system is deficient you end up being there for their benefit, rather than the other way around. It is a fine judgment to make, when to submit and when to challenge the system.

The everyday meaning of patient is ‘a person receiving medical treatment’ but as one person commented in a previous posting, its roots are in the Latin pati, to suffer.  A patient is therefore also defined as someone who ’suffers and endures the actions of others’. If you are a patient patient, you do it without complaint. 

The suffering results not just from surgery and medication, but from all kinds of smaller, regular invasions. My own bugbear is the canula: a piece of plumbing inserted into the vein which provides a port into the body’s interior. The insertion is painful and if the first attempt does not succeed, results in multiple bruises. It has an effect on the mind as well as body: the canula harpoons the patient’s private space and signals clearly to the world that one is enduring the actions of others.

There is a lot of information that medical people don’t think to volunteer, and if you don’t ask the right question, you may not get the answer. But you need information to know what questions to ask. So you become informed, using terms unimagined a short time ago. You start to make the same distinctions and comparisons as specialists.

The main change in outlook as a patient is the attitude to risk. I will look at this in the next posting of the series. Meanwhile, feedback is very welcome.

Why blood cells count

This is the first in a series of postings related to my cancer treatment. The aim is to talk about the personal experience of illness in a broadly analytical way.

I am starting with blood: what it is made of, and how that affects our very being.

Blood and its qualities have long served as powerful metaphors for the human condition. And people spend a lot of time putting things into the bloodstream to alter their mental state. In the case of medical treatments, the alterations are less voluntary.

In the case of chemotherapy, you are also taking something away from the blood’s basic composition, rather than adding to it. Chemo works by killing off cells that divide and grow rapidly. This targets cancer but also catches other, more useful, cells like hair and the bone marrow, which produces red and white blood cells. So the patient feels worse during the long treatment, not better.

What is it like to receive a dose of chemo? It is like being in a pool, and someone throws you a boulder. The boulder drags you down into the water, until you shake free and float back up to the surface. In the body, the chemicals feel heavy, like an unmoved meal. They are heavy – body weight goes up by several kilos immediately after a dose, before coming down again a day or two later. 

Medicine worries a good deal about the effect of chemo on the body; specifically about the blood cell count, because a deficiency in red cells causes anaemia, and in white cells leaves you vulnerable to infection. Medicine doesn’t worry so much about the effect on the mind. (The mind, that is, as a complex process of thought and feeling, rather than a disembodied, Cartesian object.) But even when there is no physical emergency, the lack of white cells has an impact. Without those cells, you literally have no ‘fight’; no defence against a threat to existence. And this state exists at the level of feelings, not just as a physical fact.

At the lowest point in the chemo dose’s three-week cycle, it feels humanly hard to go on living. Not because you are depressed, but because you lack the basic bodily ingredients, which we otherwise take for granted, that make living possible. And in a long course of treatment this happens not just once but over and over again, leading to an accumulated feeling of precariousness. It is this specific effect, I believe, that makes chemotherapy the dreadful experience that everyone acknowledges it to be.

Future postings will look at the business of being a ‘patient’; attitudes to risk and mortality; and the impact of serious illness on our relations with others.

Any feedback on these themes, or any others that you think I should consider, is very welcome.

Reports from the cell face

Back in April, I posted something here about the unexpected depilatory effects of chemotherapy, and asked readers if they thought there was a place for the personal in the Prospect blog. More generally, I asked, what makes writing about illness interesting to others?

The response was encouraging, both on the comments board and in private messages. To sum up, people appreciate having a clear description of things that don’t usually get noticed – sheer reporting from the cell face – and a level of analysis that can connect the particular to the general.

I started scoping out some themes right away for a series of postings, but got distracted by treatment and other major life difficulties. Now I am back. The aim is to find a language to talk about the body that is neither personal nor impersonal. It’s about a particular experience, but not “my story” in narrative. That old literary form, the personal essay, delivered by blog.

The first in the series will focus on blood: how the composition of what is flowing through our veins can affect the mind, and our existence generally.

Others will look at being a patient; the way one learns to assess risk and mortality; and the impact of serious illness on our relations with other people.

Any feedback on these themes, or indeed others that you think I should consider, is very welcome.

 

On the probability of not dying

If in doubt, the Old Left would nationalise or regulate. If in doubt the New Right would privatise or deregulate. And if in doubt, the soupy left-right blend that now unites us has its own default option: quantify and publish.

Today The Guardian reports that the government is preparing to publish the death rates of patients undergoing major surgery at NHS hospitals in England. Boris Johnson won the London mayoralty with a promise to publish New York-style ‘crime maps’, detailing the areas of London that suffer from the worst crime.

The practice of tabulating and comparing ‘outputs’ has been growing in policy for a number of years now. The production of rankings is always the highlight of the World Economic Forum’s World Competitiveness Report, in which nations around the world are placed on a chart from the most competitive to the least. And New Labour has been infamous for its league tables, especially in education. The hope in such cases has been to create incentives to alter managerial strategy or try harder. Revealing a country to be the 35th most competitive in the world is meant to be a wake-up call for them to do better (unless it’s France), as well as to give businesses an indication of where not to invest.

This policy trick is now being performed for the benefit of individual citizens, thanks to two developments. Continue reading ‘On the probability of not dying’

HIV after Aids

In her essay for Prospect this month, epidemiologist Elizabeth Pisani tells the story of the changing relationship between HIV and Aids in Britain’s gay community, and the changing behaviours associated with it.

Today, with new antiretroviral treatments available on the NHS, infection with the HIV virus is not the death-sentence it was even a decade ago. HIV-positive people can expect to live long and relatively normal lives without ever developing Aids, or the secondary conditions associated with it. It is overwhelmingly among Britain’s homosexual community that the change is being felt. Annual deaths among gay men in Britain have crashed from a peak of over 1,162 in 1994 to just 153 in 2007—and behaviours are changing to match, with fewer precautions being taken by fewer people.

All this means that, although Aids infection rates are falling, the rate of HIV prevalence is steadily climbing: the number of gay men living with HIV in Britain has more than doubled in the last decade, from around 14,400 in 1998 to over 31,000 today. Does this matter? Yes, argues Pisani, both socially and economically: the treatment of HIV is hugely expensive, while the virus itself is constantly threatening to mutate beyond the capabilities of even the most modern drugs. So what should HIV prevention look like in a post-Aids world? It’s a question, as she explains, whose complexities will be being experienced for years to come.




Bad Behavior has blocked 1193 access attempts in the last 7 days.